10/06/2021 (Agence Europe) – On Thursday 10 June, the European Parliament opposed a draft implementing regulation by the European Commission (EU) 2021/621 to establish a maximum residue level (MRL) for imidacloprid for aquatic use(see EUROPE B12736A5). Imidacloprid is a pharmacologically active substance. The objection resolution was adopted by 441 votes (232 against and 18 abstentions). The European Medicines Agency has recommended setting the MRL at 0.6mg/kg (600 µg/kg) for fin-fish....